TG THERAPEUTICS INC's ticker is TGTX and the CUSIP is 88322Q108. A total of 187 filers reported holding TG THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is 0.72 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $76,607 | +102042.7% | 3,084 | +61580.0% | 0.00% | – |
| Q1 2023 | $75 | -99.2% | 5 | -99.5% | 0.00% | – |
| Q1 2022 | $10,000 | -47.4% | 1,000 | 0.0% | 0.00% | – |
| Q4 2021 | $19,000 | -42.4% | 1,000 | 0.0% | 0.00% | – |
| Q3 2021 | $33,000 | -15.4% | 1,000 | 0.0% | 0.00% | – |
| Q2 2021 | $39,000 | – | 1,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GREAT POINT PARTNERS LLC | 5,434,783 | $60,326,000 | 5.25% |
| RA Capital Management | 9,880,323 | $109,672,000 | 3.33% |
| BRIDGER MANAGEMENT, LLC | 1,907,492 | $21,173,000 | 1.53% |
| Eversept Partners, LP | 776,323 | $8,617,185 | 1.52% |
| Opaleye Management Inc. | 579,651 | $6,434,000 | 1.26% |
| Sofinnova Investments, Inc. | 811,292 | $9,006,000 | 0.65% |
| Ikarian Capital, LLC | 316,200 | $3,510,000 | 0.57% |
| ARMISTICE CAPITAL, LLC | 800,000 | $8,880,000 | 0.51% |
| 683 Capital Management, LLC | 398,271 | $4,421,000 | 0.51% |
| Frontier Wealth Management LLC | 196,750 | $2,184,000 | 0.35% |